6781 - 6790 of 8785 Results
Title
Year
-
RESTRICTEDTitle: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 28Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027Citation Count: 162
-
OPENTitle: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 171End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28319Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28319Citation Count: 4
-
RESTRICTEDTitle: The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United StatesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 216Issue #:Start Page: 107112End Page: 107112Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107112Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107112Citation Count: 0
-
OPENTitle: Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal CordJournal Name: PharmaceuticsPublisher: MDPI AGVol: 15Issue #: 4Start Page: 1230End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/pharmaceutics15041230Best OA location URL: https://www.mdpi.com/1999-4923/15/4/1230/pdf?version=1681369684Citation Count: 8
-
OPENTitle: Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01004-6Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01004-6Citation Count: 19
-
RESTRICTEDTitle: Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarkerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.031Citation Count: 33
-
RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
OPENTitle: Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette SyndromeJournal Name: Biological Psychiatry: Cognitive Neuroscience and NeuroimagingPublisher: Elsevier BVVol: 6Issue #: 10Start Page: 961End Page: 972Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bpsc.2020.11.005Best OA location URL: https://doi.org/10.1016/j.bpsc.2020.11.005Citation Count: 40
-
OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Best OA location URL: https://scholarsphere.psu.edu/resources/29554bfc-5d79-4aa6-b1c5-e9441fea8e4aCitation Count: 8
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22